LifeStance Health Group, Inc.
LFST
$5.49
$0.091.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.56% | 10.83% | 15.99% | 18.95% | 20.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.56% | 10.83% | 15.99% | 18.95% | 20.32% |
| Cost of Revenue | 10.42% | 8.49% | 9.51% | 13.72% | 14.96% |
| Gross Profit | 10.86% | 15.90% | 31.35% | 31.78% | 34.03% |
| SG&A Expenses | 2.77% | 7.09% | 11.00% | 1.90% | -1.18% |
| Depreciation & Amortization | -24.70% | -39.04% | -33.96% | -22.97% | -4.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.22% | 4.71% | 6.74% | 7.83% | 8.56% |
| Operating Income | 81.02% | 110.01% | 106.72% | 101.51% | 63.38% |
| Income Before Tax | 73.73% | 92.91% | 76.83% | 93.10% | 56.51% |
| Income Tax Expenses | -427.90% | -700.28% | -126.55% | 103.51% | 110.03% |
| Earnings from Continuing Operations | 83.71% | 103.36% | 84.18% | 90.33% | 48.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 83.71% | 103.36% | 84.18% | 90.33% | 48.82% |
| EBIT | 81.02% | 110.01% | 106.72% | 101.51% | 63.38% |
| EBITDA | 261.31% | 134.75% | 2,508.47% | 318.13% | 113.36% |
| EPS Basic | 84.01% | 103.21% | 84.72% | 90.50% | 51.04% |
| Normalized Basic EPS | 72.73% | 93.42% | 72.31% | 84.84% | 57.02% |
| EPS Diluted | 83.69% | 103.00% | 84.72% | 90.50% | 51.04% |
| Normalized Diluted EPS | 72.73% | 93.42% | 72.31% | 84.84% | 57.02% |
| Average Basic Shares Outstanding | 1.93% | 1.84% | 3.54% | 2.12% | 4.48% |
| Average Diluted Shares Outstanding | 1.93% | 3.81% | 3.54% | 2.12% | 4.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |